sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> neurosyphilis market

report

Neurosyphilis Market, by Type (Asymptomatic Neurosyphilis, Meningeal Neurosyphilis, Meningovascular Neurosyphilis, General Paresis, Tabes Dorsalis, Others), Diagnosis (Physical Exam, Blood Test, Spinal Tap, Imaging Tests, Others), Treatment (Antibiotic Penicillin, Antibiotics Probenecid, Ceftriaxone, Others), End-user (Hospital and Clinics, Medical Research Centers, Academic Institutes, Others) – Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC394 September 2017 100+ FREE 10% CUSTOMIZATION

The contamination of spinal cord and brain is called as Neurosyphilis. It is common in those entities that have longer untreated syphilis. This is mainly caused due to bacteria called Treponema pallidum causing syphilis. For the first time, if you are getting infected by syphilis, thereis a possibility of again getting infected by neurosyphilis after 10 to 20 years. The key neurosyphilis symptoms are abnormal walk, depression, headache, incontinence, numbness in the toes, feet, or legs, tremors, visual disturbances, blindness, confusion, dementia, irritability, poor concentration, seizures, stiff neck, and weakness. Asymptomatic neurosyphilis is the most common type of all neurosyphilis.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the neurosyphilis market. The scope of this report covers the neurosyphilis market by its major segments, which include the types, applications, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The consideration of global market scenario for neurosyphilis, growing research funding, increasing clinical trials, and newer development of product are boosting the growth for global neurosyphilis market. Companies as well as government are investing larger amount of cash for deriving effective curing aspects for neurosyphilis. Adoptions of latest technology of diagnostic medical devices are also fueling the global market for neurosyphilis.
  • Several other factors such as growing awareness, escalating demand from emerging markets, support from government for improving public healthcare structure, and ever changing practices of healthcare are also key factors that are helping in the market growth of neurosyphilis. The global market for neurosyphilis is growing gradually and is anticipated to maintain its growth in the years to come.

Regionally, the global neurosyphilis market segmented into Europe, North America, Asia-Pacific, and the Rest of the World. Among these, North America is holding the major market share of the neurosyphilis globally. Also, the US is the top market revenue generator in the North America and also one of the essential markets for neurosyphilis across the globe. Certain factors are helping in the growth of neurosyphilis such as , growing research funding, increasing clinical trials, and newer development of product. The globala market for neurosyphilis in Latin America is also significantly growing. On the other hand, Europe region is the second largest market for neurosyphilis due to escalating cases of neurosyphilis. European countries incluidng UK, Germany and France are market dominating regions while the region of East Europe is also considerably growing.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s neurosyphilis market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the neurosyphilis market by the following segments:

  • Neurosyphilis Market, by Type
    • Asymptomatic Neurosyphilis
    • Meningeal Neurosyphilis
    • Meningovascular Neurosyphilis
    • General Paresis
    • Tabes Dorsalis
    • Others
  • Neurosyphilis Market, by Diagnosis
    • Physical Exam
    • Blood Test
    • Spinal Tap
    • Imaging Tests
    • Others
  • Neurosyphilis Market, by Treatment
    • Antibiotic Penicillin
    • Antibiotics Probenecid
    • Ceftriaxone
    • Others
  • Neurosyphilis Market By End-user
    • Hospital And Clinics
    • Medical Research Centers
    • Academic Institutes
    • Others

KEY MARKET PLAYERS

Key players in the neurosyphilis market include:

  • Abbott
  • Bayer AG
  • Eli Lilly and Company
  • GlaxoSmithKline plc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

TRENDING RELATED REPORT

Wireless Health Market, by Technology (WLAN, WAPN, WWAN, and WIMAX),Services (Smartphone, Tablet PC, PDA, Mobile Phone, and Pager Health Information), Applications (Healthcare Amenities, Physicians, Home Care, Telehealth, Pharmaceuticals, and Medical & Diagnostic Laboratories) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
  5. NEUROSYPHILIS MARKET, BY TYPE
    1. Segment Share
    2. By Type
      1. Asymptomatic Neurosyphilis
      2. Meningeal Neurosyphilis
      3. Meningovascular Neurosyphilis
      4. General Paresis
      5. Tabes Dorsalis
      6. Others
  6. NEUROSYPHILIS MARKET, BY DIAGNOSIS
    1. Segment Share
    2. By Diagnosis
      1. Physical Exam
      2. Blood Test
      3. Spinal Tap
      4. Imaging Tests
      5. Others
  7. NEUROSYPHILIS MARKET, BY TREATMENT
    1. Segment Share
    2. By Treatment
      1. Antibiotic Penicillin
      2. Antibiotics Probenecid
      3. Ceftriaxone
      4. Others
  8. NEUROSYPHILIS MARKET, BY END-USER
    1. Segment Share
    2. By End-user
      1. Hospital and Clinics
      2. Medical Research Centers
      3. Academic Institutes
      4. Others
  9. NEUROSYPHILIS MARKET, BY GEOGRAPHY
    1. Segment Share
    2. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Type
      3. By Diagnosis
      4. By Treatment
      5. By End-user
    3. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Type
      3. By Diagnosis
      4. By Treatment
      5. By End-user
    4. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Type
      3. By Diagnosis
      4. By Treatment
      5. By End-user
    5. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Type
      3. By Diagnosis
      4. By Treatment
      5. By End-user
  10. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2016
  11. KEY MARKET PLAYERS
    1. Abbott
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. Bayer AG
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. Eli Lilly and Company
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. GlaxoSmithKline plc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. Novartis AG
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. Pfizer Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. Sanofi
      1. Overview
      2. Key Strategies
      3. Key Developments
  12. SCALAR 360 DEGREE MARKET PERSPECTIVE
  13. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us